Vagus nerve stimulation paired with tones: randomized double-blind pilot

Record details

What this research found

At 6 weeks, 50% of paired-VNS participants had clinically meaningful THI improvement vs 28% of controls — a difference NOT statistically significant in the full cohort; benefit concentrated in the tonal, non-blast-induced subgroup.

The sponsor (MicroTransponder) later pivoted its paired-VNS platform to stroke rehabilitation (Vivistim, FDA PMA 2021); no tinnitus development since.

Limitations and conflicts of interest

Pilot size; invasive; program dormant.

Funding / conflicts: Industry-sponsored (MicroTransponder).

Primary sources

Used as evidence for

This is an original summary from the Tinnitus Evidence verified database, checked against the primary source — not a reproduction of the publisher's abstract.